sellWeak cluster of 210b5-1 plan
KUBASIK CHRISTOPHER E sold $5.3M of LHX
Chair and CEO at L3HARRIS TECHNOLOGIES, INC. /DE/. 21,351 shares at an average of $248.11, traded Oct 31, 2024, filed Nov 4, 2024.
Warning score
38Value
$5.3M
21,351 shares
Holdings after
130,506
-14% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000202058-24-000172, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 31, 2024 | MOption exercise Common Stock, Par Value $1.0010b5-1 | +21,351 | $129.85 | $2.8M | 151,857 | Nov 4, 2024 |
| Oct 31, 2024 | SOpen-market sale Common Stock, Par Value $1.0010b5-1 | -21,351 | $248.11 | $5.3M | 130,506 | Nov 4, 2024 |
| Oct 31, 2024 | MOption exercise Non-Qualified Stock Option (Right to Buy)derivative10b5-1 | -21,351 | $0.00 | $0 | 35,273 | Nov 4, 2024 |
Related signals
Other insiders at L3HARRIS TECHNOLOGIES, INC. /DE/ and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 19Weak | sell10b5-1 | LHX L3HARRIS TECHNOLOGIES, INC. /DE/ | NIEBERGALL ROSS President, Aerojet Rocketdyne | $288k | 1,373 | |
| 21Weak | sell10b5-1 | LHX L3HARRIS TECHNOLOGIES, INC. /DE/ | NIEBERGALL ROSS President, Aerojet Rocketdyne | $377k | 1,764 | |
| 21Weak | sell10b5-1 | LHX L3HARRIS TECHNOLOGIES, INC. /DE/ | NIEBERGALL ROSS President, Aerojet Rocketdyne | $394k | 1,764 | |
| 26Weak | sell 210b5-1 | LHX L3HARRIS TECHNOLOGIES, INC. /DE/ | NIEBERGALL ROSS President, Aerojet Rocketdyne | $845k | 3,250 | |
| 34Weak | sell 210b5-1 | LHX L3HARRIS TECHNOLOGIES, INC. /DE/ | NIEBERGALL ROSS President, Aerojet Rocketdyne | $741k | 2,988 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.